Routine executive compensation amendment with no direct trading signal. Monitor for any future change in control events that could trigger these enhanced severance payments.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 11 $81.65entry
- T+1 · 6mo ago 0.00%α +0.14% · $81.65
- T+5 · 6mo ago +1.70%α +1.79% · $83.04
- T+20 · 5mo ago +9.28%α +9.59% · $89.23
- T+60 · 3mo ago +27.88%α +23.48% · $104.41
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Healthequity amended employment agreements for six top executives (including CEO and CFO) to enhance severance benefits, such as additional target bonus payments upon termination without cause or following a change in control. The filing also details new vesting terms for equity awards. This is a routine compensatory arrangement with no material financial impact.
Key Facts
- CEO Scott Cutler's severance enhanced to 12 months base salary plus target bonus (or 18 months base plus 150% bonus upon change in control).
- Other executives (CFO, founder, CCO, CPO, GC) receive 12 months base salary plus target bonus upon change in control.
- New equity vesting terms: RSUs vest on termination without cause; PSUs prorated and remain eligible based on performance.
- No departures or appointments; all executives remain in place.
Financial Impact
No dollar amounts disclosed; the enhanced severance obligations are immaterial relative to company size.
Risk Factors
- None material from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001428336-26-000016 |
| Document: 0001428336-26-000016-index-headers.html | 0001428336-26-000016 |
| Document: 0001428336-26-000016-index.html | 0001428336-26-000016 |
| Document: 0001428336-26-000016.txt | 0001428336-26-000016 |
Track record
20 reports on HQY
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 3, 202613d ago Press Release Neutral 2/10 Entry $108.84 Now $104.58 −3.91% settles Dec 3
- Oct 27, 202620d ago Institutional Cluster Neutral 3/10 Entry $100.88 Now $104.58 +3.67% settles Nov 24
- Oct 19, 202628d ago Insider Cluster Neutral 2/10 Entry $96.60 Now $104.58 +8.26% settles Nov 17
- Oct 9, 20265w ago 8-K Neutral 2/10 Entry $92.03 to $102.11 Now $104.58 +13.64% ▲ +10.95% +14.22% vs SPY
- Oct 9, 20265w ago SC 13G/A Neutral 3/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers